Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Buy Rating for Controladora Vuela with Revised Price Target

Elaine Mendonca by Elaine Mendonca
January 27, 2024
in Breaking News
0
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

On January 27, 2024, Bruno Amorim, an analyst from Goldman Sachs, expressed his positive stance on Controladora Vuela (NYSE:VLRS) by maintaining a Buy rating. However, he revised the price target for the stock from $12.4 to $11.1. Amorim’s decision to adjust the price target is based on his evaluation of the company’s future performance in the stock market. Investors should take this updated price target into account when making their investment decisions.

VLRS Stock: Decline in Price Momentum, but Potential Positive Developments in After-Hours Trading

On January 27, 2024, VLRS stock experienced a decline in its price momentum, as it was trading near the bottom of its 52-week range and below its 200-day simple moving average. The price of VLRS shares decreased by $0.12 since the market last closed, representing a drop of 1.47%. However, there was a slight improvement in the stock’s performance during after-hours trading, as it rose by $0.16. After-hours trading can be volatile and may not always reflect the true market sentiment. Overall, VLRS stock had a relatively weak performance on January 27, 2024, but the slight increase in after-hours trading suggests that there may have been some positive developments surrounding VLRS that could potentially impact its future performance.

VLRS Stock Performance: Mixed Results as Total Revenue Rises, Net Income and EPS Decline

VLRS stock performances on January 27, 2024, showed mixed results as the company’s total revenue increased while net income and earnings per share (EPS) decreased. Starting with the total revenue, VLRS reported a total revenue of $2.85 billion in the past year, representing a 28.1% increase compared to the previous year. Additionally, the company’s total revenue increased by 9.06% since the last quarter, reaching $852.83 million. However, the net income for VLRS tells a different story. The company reported a net income of -$80.22 million in the past year, indicating a decrease of 176.76% compared to the previous year. Furthermore, the net income decreased by a significant 753.7% since the last quarter, reaching -$39.22 million. The earnings per share (EPS) for VLRS also experienced a decline. Over the past year, the company reported an EPS of -$0.69, reflecting a decrease of 177.49% compared to the previous year. Similarly, the EPS decreased by 750.38% since the last quarter, reaching -$0.34. Overall, VLRS stock performances on January 27, 2024, showed a mixed picture. Investors should closely monitor VLRS’s financial performance in the coming quarters to assess whether the company can address its profitability challenges and improve its earnings.

Tags: VLRS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart up

Goldman Sachs Analyst Expresses Optimism for United Rentals

KEYTRUDA Shows Promising Results as Adjuvant Therapy in Urothelial Carcinoma

MMM stock news

Citigroup Analyst Maintains Neutral Rating on Tesla with Reduced Price Target

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com